UK competition authorities fine GSK $54.5 million
4 hours ago
Britain's competition authority has fined drugmaker GlaxoSmithKline plc 37.6 million pounds ($54.5 million) for stalling the potential entry of generic competitors of an anti-depressant drug Seroxat into the marketplace.
Mylan offers to buy Swedish pharma firm Meda for $9.9 bn
Feb 11, 2016
US pharmaceutical giant Mylan said Wednesday it has struck a $9.9 billon deal to buy Meda, capping two years of dogged pursuit of the Swedish drugmaker.
FDA panel backs lower-cost version of J&J's top-selling drug
Feb 10, 2016
Federal health advisers have endorsed a lower-cost version of Johnson & Johnson's blockbuster drug Remicade, a pricey biotech medicine used to treat a number of inflammatory diseases.
A 'nudge' reduces doctors' unnecessary antibiotic prescription, study finds
Feb 09, 2016
Behavioral interventions that appealed to doctors' competitive spirits and desire to strengthen their reputations motivated them to significantly reduce unnecessary antibiotic prescriptions, a new study shows.
Effectiveness of behavioral interventions to reduce inappropriate antibiotic prescribing
Feb 09, 2016
Among primary care practices, the use of two socially motivated behavioral interventions - accountable justification and peer comparison - resulted in significant reductions in inappropriate antibiotic prescribing for acute ...
Research finds no easy answers to use of drug screening for pain patients
Feb 08, 2016
Doctors who treat patients suffering from chronic pain face a quandary, according to research from the University of Houston and the University of Texas Medical Branch. Monitoring patients through urine drug screenings, part ...
Better quality of care may reduce risk of death for patients on opioid painkillers
Feb 04, 2016
Better quality of care may reduce the risk of death for patients who are prescribed opioid painkillers for chronic pain, say Yale researchers. Their study, published Feb. 4 in the Journal of General Internal Medicine, offers ...
AstraZeneca doubles profits; warns of lower drug sales
Feb 04, 2016
British pharmaceuticals giant AstraZeneca on Thursday said its net profits more than doubled in 2015, adding it expects lower sales this year on US patent expiry of cholesterol treatment Crestor.
Use of opioid painkillers increases fourfold in Australia in 10 years
Feb 03, 2016
Use of common opioid painkillers such as codeine, morphine and oxycodone has more than quadrupled in Australia over the past decade and doubled worldwide over the same period a report published today in The Lancet (3rd February ...
Improved vigilance of non-prescription medicine needed to reduce abuse, according to new survey
Feb 02, 2016
A cross-sectional survey has been used to estimate the prevalence of self-reported non-prescription medicine misuse, which has found that almost a fifth of people could have misused medicines in some way over their lifetime. ...